daratumumab
janssen
['daratumumab', 'aquila', 'janssen', 'janssenus']
we have completed enrollment on the aquila randomized trial of daratumumab vs observation in high risk smoldering myeloma. 390 pts randomized. efficacy analysis will be performed after ~165 pfs events have occurred. #asco22 
Editor-in-Chief, Blood Cancer Journal; Giants of Cancer Care Award (2019); Opinions are personal views; Also @CovidThreads; https://t.co/HOGYJSpsoG